Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19
Clinical trial NCT04347681 · COMPLETED
Trial details
- NCT number
- NCT04347681
- Sponsor
- King Fahad Specialist Hospital Dammam
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-18
- Primary completion
- 2020-11-01
- Enrollment
- 575
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.